Breaks Categories: News

ThursdayDec 18, 2025 11:37 am

NetworkNewsBreaks – BluSky Ai Inc. (OTCID: BSAI) Featured in Research Report Highlighting Scalable GPU-Centric AI Platform

BluSky Ai (OTCID: BSAI), a developer of artificial intelligence infrastructure software, was the subject of a December 2025 independent research report published by Globe Small Cap Research LLC that reviewed the company’s distributed GPU-centric AI platform and its potential role in addressing growing demand for scalable compute resources. The report examines BluSky Ai’s centralized cloud software architecture designed to aggregate geographically dispersed GPU modules into a single elastic pool, enabling enterprises and public-sector users to deploy AI workloads without relying solely on traditional centralized data centers. According to Globe Small Cap Research, BluSky Ai’s software-driven approach is positioned to benefit from accelerating demand…

Continue Reading

ThursdayDec 18, 2025 11:26 am

NetworkNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Enables SEC-Registered Equity to Be Used in DeFi via Solana

Forward Industries (NASDAQ: FWDI) announced that its SEC-registered shares are now live on the Solana blockchain through Superstate’s Opening Bell platform, marking the first time a public company’s equity can be used directly within decentralized finance, with tokenized FWDI shares available for eligible ex-U.S. holders to post as collateral on Kamino, a leading Solana-based lending protocol. The company said the integration allows investors to borrow stablecoins against their equity while maintaining exposure to FWDI stock, supported by real-time price feeds from Pyth, and distinguishes itself from synthetic tokenized stock models by directly tokenizing Forward’s Class A Common Stock through Superstate, a registered SEC transfer agent. Forward…

Continue Reading

ThursdayDec 18, 2025 11:07 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Publishes Positive Phase 2a SGX945 Data in Behçet’s Disease 

Soligenix (NASDAQ: SNGX) announced that results from its Phase 2a proof-of-concept study evaluating SGX945 (dusquetide) for the treatment of aphthous ulcers associated with Behçet’s Disease have been published in Rheumatology (Oxford), reporting beneficial effects in seven of eight patients with sustained improvement through a four-week follow-up period after treatment ended. The company said outcomes for SGX945, including reductions in oral ulcers and pain and favorable area under the curve measurements, were comparable to those reported in a Phase 3 study of apremilast (Otezla(R)), despite SGX945 dosing stopping at Week 4 while apremilast required continuous administration. Soligenix noted SGX945 was well tolerated with no treatment-related adverse events observed and said it…

Continue Reading

ThursdayDec 18, 2025 10:57 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Responds to Fentanyl WMD Executive Order, Highlights AVERSA(TM) FENTANYL Development

Nutriband (NASDAQ: NTRB) said the Trump Administration Executive Order designating illicit fentanyl and its core precursor chemicals as weapons of mass destruction should not be conflated with “FDA”-approved prescription fentanyl therapies such as transdermal fentanyl patches, which it said are produced under rigorous regulatory oversight and remain medically necessary for certain severe chronic pain patients. The White House+1 The company noted ongoing concerns around transdermal fentanyl patch abuse and accidental pediatric exposure and said it is partnering with Kindeva to develop AVERSA(TM) FENTANYL, which combines Nutriband AVERSA(TM) abuse-deterrent technology with Kindeva FDA-approved fentanyl patch to deter abuse and reduce accidental exposure while maintaining access for patients who need prescription fentanyl products. Nutriband said AVERSA(TM)…

Continue Reading

ThursdayDec 18, 2025 10:00 am

NetworkNewsBreaks – Massimo Group (NASDAQ: MAMO) Launches Fleet and Commercial Vehicle Program, Expands Beyond Retail Channels

Massimo Group (NASDAQ: MAMO) announced the launch of a dedicated Fleet and Commercial Vehicle Program, marking a strategic expansion beyond traditional retail sales and targeting fleet-oriented customers such as security operations, municipalities, campuses, grounds maintenance providers, and commercial facilities. The manufacturer and distributor of powersports and electric vehicles said the program will initially focus on its newly introduced MVR HVAC electric vehicle series, which features fully enclosed cabs with heating and air conditioning designed for high-utilization, year-round operation, with a structured go-to-market strategy that includes direct fleet engagement, trade show participation, and dedicated commercial sales efforts to support repeat purchasing and…

Continue Reading

ThursdayDec 18, 2025 9:40 am

NetworkNewsBreaks – GlobalTech Corp. (OTC: GLTK) Closes Acquisition of Controlling Stake in Moda In Pelle

GlobalTech (OTC: GLTK) announced the closing of its previously disclosed definitive agreement to acquire a 51% controlling interest in 123 Investments Limited, doing business as Moda in Pelle, a premium U.K. footwear brand founded in 1975, in a transaction intended to add a new revenue stream and expand the company’s direct-to-consumer and e-commerce capabilities. The U.S.-based technology holding company said the acquisition supports the planned deployment of its Thrivo AI platform within the Moda in Pelle ecosystem and strengthens its operational footprint in the U.K., with consideration consisting of shares of GlobalTech common stock and Convertible Series A Preferred Stock,…

Continue Reading

ThursdayDec 18, 2025 9:20 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Eliminates Balance Sheet Debt Through Anson Equity Conversion

NRx Pharmaceuticals (NASDAQ: NRXP) announced it has repaid the remaining $5.4 million of balance sheet debt owed to Anson Funds LLC through an equity conversion into common stock with no warrants or repricing mechanisms, fully retiring the original $16.2 million loan used for prior debt repayment and operating expenses. With the transaction completed, the clinical-stage biopharmaceutical company expects to end calendar year 2025 debt free, positioning its capital structure to support anticipated drug approvals and clinic expansions, with Chairman and CEO Dr. Jonathan Javitt thanking Anson for its support during a challenging biotech market and citing progress toward potential 2026…

Continue Reading

ThursdayDec 18, 2025 9:10 am

NetworkNewsBreaks – Fairchild Gold Corp. (TSX-V: FAIR) Highlights High-Grade Copper Results and Advancing Drill Targets at Nevada Titan Project

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising. Fairchild Gold (TSX-V: FAIR) highlighted recent exploration progress at its Nevada Titan Project, located approximately 26 miles southwest of Las Vegas, where surface sampling has outlined a 1.5-kilometer discontinuous copper trend and numerous high-grade copper values of up to 34% Cu across multiple historic mine areas. Recent high-resolution drone magnetic surveying identified eight distinct underground magnetic targets, including a compact, steeply oriented “Pipe Target” that aligns with surface geology and strongly magnetic skarn-related mineralization, supporting the Company’s belief that the project hosts a porphyry-style…

Continue Reading

WednesdayDec 17, 2025 12:42 pm

NetworkNewsBreaks – MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Closes $5 Million Private Placement With Vietnam-Based Strategic Partner 

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) OTC: MAXXF) (FRANKFURT: 89N) has closed a non-brokered private placement for gross proceeds of $5 million (CDN), marking the first large investment by a Vietnam-based company in Saskatchewan and forming part of a strategic partnership with Bitexco affiliate Big Energy. The investment supports accelerated exploration and potential commercial development of natural hydrogen across MAX Power 1.3 million-acre permitted land package in Saskatchewan, positioning the Company to advance discovery efforts within what is emerging as a new primary clean energy sector. To view the full press release, visit https://nnw.fm/61nZr About MAX Power…

Continue Reading

WednesdayDec 17, 2025 12:24 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Rami Levin as President and Chief Executive Officer

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for primary and metastatic cancers of the brain and central nervous system, reported a leadership transition under which John Climaco has stepped down as chief executive officer and Rami Levin, MBA, has been appointed president and chief executive officer, effective Jan. 1, 2026. Levin brings nearly three decades of global leadership experience across oncology, neurology and rare diseases, with a track record of advancing late-stage clinical programs, scaling organizations and leading strategic turnarounds, positioning CNS to advance its pipeline and next phase of development. To view the full press release, visit https://nnw.fm/dVe30 About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a…

Continue Reading